TP53 and cancer: Using the UALCAN and the Xiantao tool, we investigated the relationship between TIMM13 expression and several clinicopathological features, such as tumor type, stage, lymph node stage, and TP53 mutation shown in Figure 2A, the expression of TIMM13 in SKCM metastatic cancer tissues was significantly higher than that in primary cancer tissues and normal cancer tissues (p = 0.